MicroRNA155 in non-small cell lung cancer: a potential therapeutic target
Lung cancer (LC) is the second most commonly diagnosed cancer among both men and women, and it stands as the leading cause of cancer-related mortality, characterized by high rates of morbidity and mortality. Among its subtypes, non-small cell lung cancer (NSCLC) is the most prevalent and one of the...
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Frontiers Media S.A.
2025-02-01
|
| Schriftenreihe: | Frontiers in Oncology |
| Schlagworte: | |
| Online Zugang: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1517995/full |